New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

about

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

Item

http://www.wikidata.org/entity/Q47296036

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@en

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@nl

type

Item

label

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@en

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@nl

prefLabel

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@en

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@nl

P1476

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.

@en

P2093

Andrew Ustianowski

http://www.w3.org/2001/XMLSchema#string

Faydra I Lieveld

http://www.w3.org/2001/XMLSchema#string

Joop E Arends

http://www.w3.org/2001/XMLSchema#string

Shazaad Ahmad

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

Molecular mechanisms of T cell co-stimulation and co-inhibition

HIV-1 entry inhibitors: recent development and clinical use

Changing the face of hepatitis C management - the design and development of sofosbuvir

The blockade of immune checkpoints in cancer immunotherapy

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

T-Cell Function and Migration — Two Sides of the Same Coin

T cell exhaustion

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B

P2888

s40121-017-0173-y

P304

461-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-017-0173-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29071665

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

5700893

http://www.w3.org/2001/XMLSchema#string